Ignite is an online matchmaking event that addresses the latest challenges of pharma and healthcare, by connecting established companies with providers of disruptive technology solutions. As a provider of a platform that has the potential to disrupt specialist cancer diagnostics, Rarity Bioscience has been invited to matchmaking with several potential partners in research, pharma and healthcare.
Our technology Rarity SafeLock, offers unprecedented, ultra-sensitive detection of mutated nucleic acid sequences based on fast read-out on well-established flow cytometry. Are you interested in knowing more?
Meet up with us at Ignite.